
Invert provides software that unifies bioprocess data for monitoring, analysis, reporting, and modeling across biopharma, synthetic biology, and CDMO teams.
Invert focuses its software on bioprocess development and manufacturing workflows, connecting instrument and enterprise-system data with experimental and run context. Its product materials describe metric harmonization and lineage across process steps, alongside monitoring and analysis features.
The company also documents connectors for laboratory and manufacturing systems and describes traceable, reproducible analysis outputs. These capabilities position its platform around bioprocess-specific data organization rather than general-purpose data analytics alone.
Source: invertbio.com
Invert's public pricing page does not list fixed prices; it asks prospective customers to describe their technology stack and operational setup for a tailored estimate. This makes public price comparisons difficult for buyers who want to evaluate costs before contacting the company.
The company's site presents its software for biopharma, synthetic biology, and contract development and manufacturing teams, a narrower domain than broad data-management platforms. Prospective customers outside bioprocessing may find fewer directly relevant workflows among its stated use cases.
Source: invertbio.com
Invert's software links bioreactors, historians, laboratory systems, and electronic lab notebooks to organize process data around experiments and production runs. The company describes support for live monitoring, data quality workflows, analysis, reporting, and process modeling.
Its platform includes a data foundation, run monitoring and exploration tools, and bioprocess-oriented intelligence features. Invert also offers integrations for instruments and enterprise systems used in biopharmaceutical development and manufacturing.
Source: invertbio.com